Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLS | KROS | FULC | ||
| Company | Sellas Life Sciences Group Inc | Keros Therapeutics Inc | Fulcrum Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.59 | 17.45 | 9.71 | ||
| High | 3.83 | 17.90 | 10.00 | ||
| Low | 3.55 | 17.35 | 9.61 | ||
| Latest | 3.73 | 17.57 | 9.74 | ||
| Change | +0.20 | +0.33 | +0.19 | ||
| % Change | +5.67% | +1.91% | +1.99% | ||
| Volume | 5,470,600 | 305,400 | 489,200 | ||
| 20-Day Average Volume | 7,665,325 | 299,855 | 686,345 | ||
| Previous Close | 3.53 | 17.24 | 9.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.04 | 18.59 | 10.39 | ||
| 20-Day Raw Stochastic | 31.06% | 12.87% | 30.24% | ||
| 20-Day Relative Strength | 52.43 | 42.97 | 43.90 | ||
| Weighted Alpha | +111.62 | +44.70 | +25.45 | ||
| Today's Opinion | 88% Buy | 24% Buy | 24% Buy | ||
| Previous Opinion | 88% Buy | 24% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.06% since 01/30/26 | -1.90% since 01/30/26 | -9.23% since 01/30/26 | ||
| Low | 3.48 on 02/05/26 | 17.22 on 02/05/26 | 9.52 on 02/05/26 | ||
| High | 4.20 on 02/03/26 | 18.74 on 02/03/26 | 11.11 on 02/02/26 | ||
| 1-Month | |||||
| %Chg | -9.02% since 01/06/26 | -1.24% since 01/06/26 | -2.50% since 01/06/26 | ||
| Low | 3.23 on 01/09/26 | 17.22 on 02/05/26 | 9.07 on 01/12/26 | ||
| High | 4.84 on 01/22/26 | 19.94 on 01/23/26 | 11.29 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +130.25% since 11/06/25 | +8.66% since 11/06/25 | +27.32% since 11/06/25 | ||
| Low | 1.39 on 12/02/25 | 15.89 on 11/07/25 | 7.27 on 11/07/25 | ||
| High | 5.18 on 01/05/26 | 22.55 on 12/08/25 | 15.74 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +134.59% since 08/06/25 | +21.93% since 08/06/25 | +40.35% since 08/06/25 | ||
| Low | 1.39 on 12/02/25 | 13.13 on 08/07/25 | 6.28 on 08/11/25 | ||
| High | 5.18 on 01/05/26 | 22.55 on 12/08/25 | 15.74 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,309 | 535,287 | 527,109 | ||
| Shares Outstanding, K | 142,442 | 30,466 | 54,118 | ||
| Annual Sales | 0 | 3,550,000 | 80,000,000 | ||
| Annual Net Income | -30,880,000 | -187,350,000 | -9,730,000 | ||
| Last Quarter Sales | 0 | 14,260,000 | 0 | ||
| Last Quarter Net Income | -6,790,000 | -7,280,000 | -19,600,000 | ||
| 60-Month Beta | 2.27 | 0.86 | 3.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/12/25 | -0.18 on 11/05/25 | -0.31 on 10/29/25 | ||
| Latest Earnings Date | 03/19/26 | 02/25/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.19 | 0.00 | ||